https://apnews.com/3d281d0a09f18c5a671ca030b332a7bc

Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecast after sharply after blowing past Wall Street expectations.

The company, along with its German partner BioNTech, now anticipate sustained revenue from their COVID-19 vaccine with the world far from herd immunity against the virus. New contracts to supply vaccines to countries as far out as 2024 continue to be signed.